ArticleMolecular endocrinology (Baltimore, Md.)2013

Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).

Kuo-Pao Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.